S4: Electrically Charged Minerals Patent-Pending Technology and Its Role in Treating SARS-CoV-2
S4 is an innovative, patent-pending technology that involves the use of electrically charged minerals designed to target and neutralize harmful pathogens, including viruses like SARS-CoV-2 (commonly known as COVID-19). This technology harnesses the power of specialized minerals that have been electrically charged, giving them unique properties that make them effective in disrupting the structure and function of viruses.
What is S4?
S4 is based on the principle of using minerals that have been charged with electricity in a way that enhances their ability to interact with and neutralize pathogens. These minerals, once electrically charged, take on a specific electrical charge that allows them to bond with various elements of harmful microorganisms, including the virus that causes COVID-19.
This technology does not rely on traditional chemical methods but instead uses a physical process that disrupts the virus’s outer structure, making it less capable of infecting healthy cells in the body. By leveraging the natural properties of minerals that can be activated electrically, S4 offers a novel approach to pathogen management, particularly in fighting viral infections like SARS-CoV-2.
How Does S4 Work to Treat SARS-CoV-2?
SARS-CoV-2, like many other viruses, has a protective outer layer, often referred to as the viral envelope. This envelope is essential for the virus to enter and infect host cells. S4 technology works by using electrically charged minerals that interact with this viral envelope. Here’s how it functions:
1. Charge Interaction: When these minerals are exposed to the virus, their electrical charge disrupts the integrity of the virus’s membrane or envelope. The charged minerals can interact with the virus in a way that destabilizes its structure.
2. Disruption of Virus Function: The destabilization caused by the charged minerals prevents the virus from effectively binding to host cells. Without this binding ability, the virus cannot initiate the infection process and replicate within the body, reducing its ability to spread and cause harm.
3. Inactivation of Virus: Through this method, the virus is rendered inactive, meaning it cannot attach to cells and start the infection process. This is crucial for preventing the spread of the virus within the body, offering a proactive means to reduce the viral load and limit the impact of the infection.
4. Non-Toxic and Targeted: Unlike traditional antiviral treatments, which may come with side effects, S4 technology targets the viral structure directly, minimizing the potential for harm to healthy cells or tissues. This makes it an ideal candidate for integration into treatments aimed at controlling or preventing viral infections like COVID-19.
The Benefits of S4 in Treating SARS-CoV-2
The primary advantage of S4’s technology in treating SARS-CoV-2 is its ability to treat the virus without relying on chemicals or pharmaceuticals. Here are a few key benefits:
- Reduced Resistance: Unlike some antiviral drugs that can lead to resistance over time, the mechanism behind S4, which uses electrically charged minerals, offers a more sustainable way to manage the virus without the risk of developing resistance.
- Broad Spectrum: While currently being studied for its effectiveness against SARS-CoV-2, S4 has the potential to treat other viral infections as well. Its ability to target the physical structure of viruses makes it a versatile technology for fighting multiple types of harmful pathogens.
- Non-invasive Treatment: S4 technology could be incorporated into various forms of treatment, such as nasal sprays, sprays for surfaces, or other therapeutic delivery systems, offering a non-invasive way to neutralize viral particles.
- Compatibility with Other Treatments: S4 could be used in conjunction with vaccines or other antiviral therapies, providing an additional layer of protection against viral infections and enhancing the overall effectiveness of public health measures.
Final Thoughts
S4 is a cutting-edge, patent-pending technology that represents a potential breakthrough in the fight against SARS-CoV-2 and other viral pathogens. By using electrically charged minerals to disrupt the viral structure, S4 offers a novel, non-chemical approach to inactivating viruses, reducing their ability to infect and spread. As research continues, S4 could become an integral part of new antiviral therapies, providing a safe, effective, and targeted solution to combating COVID-19 and other viral infections.
Abstract
S4 is a patent-pending technology and is 100% natural. Is a new type of aqueous nutraceutical which is antipathogenic in nature due to pathogen specific electrical charge properties. Thousands of people have been treated with this product when delivered through an existing network of medical professionals validating its efficacy and safety. Using FDA guidelines, S4 was evaluated for wellness benefits as a potential investigational drug under medical supervision using 52 volunteers (Group1: 15 and Group2: 37) in an institutional setting (The Lovelady Center (TLC) in Birmingham, Alabama) using quantitative measurements of vital signs along with two qualitative self-reported questionnaires. The results indicate a highly significant improvement in vital signs and a significant reduction in various physiological and emotional conditions.
At the start of the study, the average temperature and oxygen values were subnormal, indicating poor health status, whereas, by the end of the study, vital signs were all normal. During the study, a cohort study (proof of concept) was conducted with 14 individuals, in the TLC general population, who were identified and diagnosed as COVID-19 positive. After 6 days (on average) of S4 administration, a shift of their COVID-19 status switched to negative, and a complete reversal of symptoms were observed several times faster than predicted by the CDC [1]. Of particular interest were oxygen levels because a previous in-vitro pilot study indicated that dissolved oxygen levels doubled with “S4” -It is postulated that this is an important mechanism promoting an immediate sense of wellness.
The present study demonstrated the clinical benefits of short-term use of S4. Vital sign measurements indicated a significant change toward normal body temperatures and overall increase in blood oxygen levels. In addition, several other wellness parameters changed, including improvements in energy, focus, and sleeping. Additional benefits were seen in daily surveys for decreasing depression and anxiety, increasing happiness, improving breathing (where a difficulty was initially observed), reducing congestion, and decreasing chronic pain. Assessment of medical histories and additional notated conditions were lessened in severity for asthma, heart and lung conditions, various pains, stomach conditions, headaches, and skin conditions. There were no side effects noted during the study. The results from this study, and the preliminary observations from previous unpublished reports, indicate that there are many positive benefits towards wellness that can be gained from S4.
